| Literature DB >> 25722877 |
Zheng Jie Marc Ho1, Yi Fu Jeff Hwang1, Jian Ming Vernon Lee1.
Abstract
The communal nature of living and training environments, alongside suboptimal hygiene and stressors in the field, place military personnel at higher risk of contracting emerging infectious diseases. Some of these diseases spread quickly within ranks resulting in large outbreaks, and personnel deployed are also often immunologically naïve to otherwise uncommonly-encountered pathogens. Furthermore, the chance of weaponised biological agents being used in conventional warfare or otherwise remains a very real, albeit often veiled, threat. However, such challenges also provide opportunities for the advancement of preventive and therapeutic military medicine, some of which have been later adopted in civilian settings. Some of these include improved surveillance, new vaccines and drugs, better public health interventions and inter-agency co-operations. The legacy of successes in dealing with infectious diseases is a reminder of the importance in sustaining efforts aimed at ensuring a safer environment for both military and the community at large.Entities:
Keywords: Communicable diseases; Emerging; Infectious disease medicine; Military personnel
Year: 2014 PMID: 25722877 PMCID: PMC4341224 DOI: 10.1186/2054-9369-1-21
Source DB: PubMed Journal: Mil Med Res ISSN: 2054-9369
Figure 1Challenges and opportunities of emerging and re-emerging infectious diseases in the military.
Infectious diseases during military deployments and measures implemented
| Operation | Year | Infectious diseases | Measures implemented |
|---|---|---|---|
|
| 1861 to 1865 | Malaria [ | Use of Quinine |
|
| 1914 to 1918 | 1918 Influenza [ | Improvements in respiratory hygiene and isolation |
| Trench Foot [ | Footwear modifications | ||
| Foot protection (grease, borated talc and camphor) | |||
| Measures to improve trench and boot drainage | |||
| Tetanus [ | Prophylactic Anti-Tetanus serum to wounded | ||
|
| 1939 to 1945 | Wound infections [ | Use of Dakin’s solution for antisepsis |
| Use of Sulfanilamide and Penicillin | |||
| Scrub Typhus [ | Development of delousing strategies | ||
| Malaria [ | Use of Atabrine | ||
| Lymphatic Filariasis [ | |||
|
| 1950 to 1953 | “Korean Haemorrhagic Fever” (Hanta virus) [ | Improvement in environmental health measures |
|
| 1953 to 1975 | Malaria and Dengue [ | Mosquito nets and repellents, Antimalarials including Mefloquine - designed by army to counter Chloroquine resistance. |
| Bubonic Plague (Yersinia pestis) [ | Flea insecticide and repellents | ||
| Immunisation with plague vaccines | |||
| Protective clothing and Rat proofed dwellings | |||
|
| 1990 to 1991 | Preparedness against Biological Warfare [ | Anthrax, Botulinum, Meningococcus vaccines and Hepatitis A immunoglobulins |
|
| 1993 | Malaria [ | Use of Mefloquine and Doxycycline |
|
| 2001 to 2011 | Leishmaniasis [ | Genus specific probe for diagnosis |
|
| Treatment modalities under investigational new drug protocols | ||
|
| Better shelters and insect repellents | ||
| Malaria [ | Use of rapid diagnostic assays and Tafenoquine | ||
| Norovirus and Shigella [ | Use of rapid diagnostic assays | ||
| Segregation and enforcement of hygiene | |||
| Multidrug Resistant Wound infections and Nosocomial Transmission (especially Acinetobacter baumanii) [ | Improvements in infection control practices, antibiotic restriction policies | ||
| Admission surveillance cultures of wounded soldiers and contact isolation | |||
| Need for new antibiotics targeting resistant Gram negative bacteria |
Figure 2Selected infectious diseases during military deployments [ [1] - [4] , [7] - [9] , [15] , [26] , [28] - [30] , [39, 41] , [44] , [50] - [61] ].
Vaccinations and military contributions [85–89]
| Vaccine | Year initiated | Military role |
|---|---|---|
|
| 1777 | Used by the Continental Army in 1777; Used by Prussian Army during the Franco-Prussian War in 1870 |
|
| 1900 | Demonstration of etiological agent and vector |
|
| 1909 | British Army used early forms during the Anglo-Boer War; US Military developed killed typhoid vaccine for US Army and Navy personnel |
|
| 1940 | Used by the US Army and Navy from 1940; Used by the Luftwaffe in World War II |
|
| 1940, 1980s | Injectable whole cell vaccines given to alert US Military Units until 1973 |
|
| 1945, 1985 | US Military developed immunoglobulins and used in Korea and Vietnam in the 1960s; US Military supported safety, immunogenicity and efficacy studies |
|
| 1945 | US Military tested first multivalent polysaccharide vaccine |
|
| 1950s | US Military sponsored reduced dose formulation |
|
| 1950s | Early anthrax vaccines were developed by Dr George Wright of the U.S. Chemical Corps and his colleagues, and were licensed in 1970. |
|
| 1952-1969 | US Military developed killed bivalent and oral attenuated vaccine |
|
| 1957 | US Military developed first iterations of influenza vaccines and conducted trials among US service members |
|
| 1950s, 1980s | US Military performed vaccination efforts in World War II and later supported inactivated vaccine studies |
|
| 1960s | US personnel in Vietnam and Southern Vietnam soldiers vaccinated in the 1960s |
|
| 1968 | US Military developed polysaccharide vaccine and supported clinical trials; Adopted by the Israeli Army in 1994 |
|
| 1972 | US Military developed technique for isolating virus used to develop the vaccine |
|
| 1980 | US Military provided funding for development of an attenuated vaccine |